Recital 5, Regulation (EU) 2024/2174

In force

For small products falling within the scope of points (f) to (h) of Article 12(1) of Regulation (EU) 2024/573, it is necessary to provide for practicable ways to convey the required information to the users, including by using digitally readable links to the information referred to in Article 12(3), points (b) and (c). In order to take into account the specific requirements of labelling of products and equipment for medical uses in the scope of Directive 2001/83/EC of the European Parliament and of the Council [Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001, p. 67).] and Regulations of the European Parliament and of the Council (EC) No 726/2004 [Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.4.2004, p. 1).], (EU) 2019/6 [Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (OJ L 4, 7.1.2019, p. 43).] and (EU) 2017/745 [Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC (OJ L 117, 5.5.2017, p. 1).] and laid down in those legal acts, additional methods to present the required information to users should be provided for as regards those products and equipment.